The words of Dr Martin Luther King Jr. still echo, “of all the forms of inequality, injustice in healthcare is the most shocking and inhumane.” In Ghana today, few issues capture this truth more clearly than cervical cancer, a largely preventable diseasenues to claim the lives of far too many women.

Every year, thousands of Ghanaian women are diagnosed with cervical cancer, and many do not survive it  not because the disease is not treatable, but because it is often detected too late, managed too slowly, or made too expensive to fight. Behind every statistic is a woman: a mother, a sister, a daughter, a professional, a breadwinner. And behind her is a family whose emotional and financial world is often turned upside down.

What makes cervical cancer especially painful is that it should not be killing women in the 21st century. With the HPV vaccine, routine screening, early treatment, and proper follow-up care, this disease can be prevented or detected early enough to save lives. Many countries are already on the path to eliminating it as a public health threat.

But this is not just a conversation about mortality. A diagnosis of cervical cancer does not only bring physical pain or death; it brings fear, anxiety, depression, stigma, and financial stress. Women worry about their children, their marriages, their work, and their future. Families sell property, drain savings, and rearrange their lives around care. In many homes, the disease becomes not just a medical condition, but a social and economic crisis.

This is where we must ask difficult but necessary questions. When a woman in Ghana is diagnosed with cervical cancer, how available is the health system to walk with her through the journey? Are there funds she can rely on? Are services close to her, or only in big cities? Does her mental health receive the same attention as her physical treatment? And what happens if she lives in a rural or underserved community?

We have made some important progress as a country.  Ghana’s recent rollout of the HPV vaccine for young girls is a major investment in the future. It tells us that the country is thinking ahead, but vaccination alone will not solve today’s problem. Millions of adult women are already at risk, and screening coverage in Ghana remains worryingly low, as many women have never been screened even once in their lives.

On financing, the National Health Insurance Scheme (NHIS)  covers aspects of cervical cancer treatment, which is commendable. And the new MahamaCares (Ghana Medical Trust Fund) initiative offers fresh hope for people living with chronic diseases, including cancers.

These are important policy signals. But in practice, too many women still face high out-of-pocket costs, long delays, and limited access to specialised care. A health system that protects dignity must not only exist on paper; it must work in real time, for real people, in real communities.

We must also confront the rural reality. A woman in a remote part of the country is less likely to be screened, less likely to be diagnosed early, and less likely to complete treatment. This is not because her life is less valuable, but because our systems are still too unevenly distributed.

This is why cervical cancer is not only a health issue but also an equity,  development, and a justice challenge.

If we are serious as a country, then January, Cervical Cancer Awareness Month, should not be about posters and slogans alone. It should be a moment of policy courage.

We must expand screening nationwide, integrate services into primary healthcare and fully fund prevention. Make NHIS coverage more comprehensive and more practical. Ensure MahamaCares reaches women quickly and transparently. And build a system that supports not just the body, but also the mind and the community.

No woman in Ghana should die from a disease we know how to prevent. No family should be impoverished by a condition we know how to manage. And no nation should accept injustice in healthcare as normal.

Dr. Martin Luther King was right. And the time to act on that truth is now.